Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Grifols S.A. ADR (GRFS)

Grifols S.A. ADR (GRFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Grifols S.A. ADR 152-158 PARC DE NEGOCIS CAN SANT JOAN SANT CUGAT DEL VALLS BARCELONA U3 08174 ESP

www.grifols.com Employees: 23,737 P: 34-93-571-2200 F: +34 938008000

Description:

Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.

Key Statistics

Overview:

Market Capitalization, $K 5,913,016
Enterprise Value, $K 17,307,086
Shares Outstanding, K 687,560
Annual Sales, $ 7,135 M
Annual Net Income, $ 64,200 K
Last Quarter Sales, $ 1,972 M
Last Quarter Net Income, $ 56,840 K
EBIT, $ 1,216 M
EBITDA, $ 1,695 M
60-Month Beta 0.50
% of Insider Shareholders 0.19%
% of Institutional Shareholders 0.00%
Float, K 686,254
% Float 99.81%
Short Volume Ratio 0.45

Growth:

1-Year Return -11.68%
3-Year Return -21.17%
5-Year Return -62.41%
5-Year Revenue Growth 34.64%
5-Year Earnings Growth -91.45%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings 0.02 on 07/30/24
Next Earnings Date 08/01/24
Earnings Per Share ttm 0.02
EPS Growth vs. Prev Qtr 280.29%
EPS Growth vs. Prev Year -77.78%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.370 on 06/03/21
Next Ex-Dividends Date 06/03/21
Dividend Payable Date 06/14/21
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 01/04/16

GRFS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 10.57
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.90%
Debt/Equity 1.23
Price/Sales 0.79
Price/Cash Flow 10.72
Price/Book 0.67
Book Value/Share 0.00
Interest Coverage -1.38

GRFS Dividends

Date Value
06/03/21 $0.3700
10/30/20 $0.1430
12/02/19 $0.1700
06/27/19 $0.1310
06/07/19 $0.0090
11/30/18 $0.1750
06/04/18 $0.1930
12/01/17 $0.1630
05/30/17 $0.1220
12/05/16 $0.1550
06/02/16 $0.1130
12/10/15 $0.3100
06/08/15 $0.3418
12/04/14 $0.3128
06/05/14 $0.2869
06/05/13 $0.2587
05/29/13 $0.0128
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar